• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于制定药品和医疗产品优先排序框架的系统评价。

Systematic review for the development of a pharmaceutical and medical products prioritization framework.

作者信息

Frutos Pérez-Surio Alberto, Gimeno-Gracia Mercedes, Alcácera López Ma Aránzazu, Sagredo Samanes Ma Asunción, Pardo Jario Ma Del Puerto, Salvador Gómez Ma Del Tránsito

机构信息

Department of Hospital Pharmacy, University Clinical Hospital Lozano Blesa. Avda. San Juan Bosco 15, 50009 Zaragoza, Spain.

2Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, C/Domingo Miral s/n 50009, Zaragoza, Spain.

出版信息

J Pharm Policy Pract. 2019 Aug 21;12:21. doi: 10.1186/s40545-019-0181-2. eCollection 2019.

DOI:10.1186/s40545-019-0181-2
PMID:31452901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6702737/
Abstract

OBJECTIVE

To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

DATA SOURCES

We performed a search of the main biomedical databases (Medline/PubMed, Embase, Centre for Reviews and Dissemination, and Cochrane), and we reviewed assessment agency websites, among other sources.

STUDY DESIGN

An systematic review of the literature was carried out.

DATA COLLECTION

Eligibility criteria for inclusion were based on set of predefined criteria. Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. A critical analysis is made of all the aspects that may be useful for any public body that intends to establish priorities in health.

PRINCIPAL FINDINGS

We found that there are no standardized criteria for priority setting, although common trends have been identified regarding key elements. Eight key domains were identified: 1) need for intervention; 2) health outcomes; 3) type of benefit of the intervention; 4) economic consequences; 5) existing knowledge on the intervention/quality and uncertainties of the regarding evidence; 6) implementation and complexity of the intervention/feasibility; 7) justice and ethics; and 8) overall context.

CONCLUSIONS

Our review provides a thorough analysis of the relevant issues and offers key recommendations regarding considerations for developing a national prioritization framework. Findings are envisioned to be useful for different public organizations that are aiming to establish healthcare priorities.

摘要

目的

识别并分析用于确定国家/国际卫生优先事项的标准、方法和概念框架。

数据来源

我们检索了主要的生物医学数据库(Medline/PubMed、Embase、循证医学与传播中心及考克兰系统评价数据库),并查阅了评估机构网站等其他来源。

研究设计

对文献进行系统评价。

数据收集

纳入标准基于一组预先确定的标准。纳入旨在确定优先排序标准或制定卫生优先事项选择通用操作框架的系统评价和/或定性研究(访谈、调查、专家共识等)。对任何有意确定卫生优先事项的公共机构可能有用的所有方面进行批判性分析。

主要发现

我们发现,虽然已确定了关于关键要素的常见趋势,但尚无确定优先事项的标准化标准。确定了八个关键领域:1)干预需求;2)健康结果;3)干预的益处类型;4)经济后果;5)关于干预的现有知识/相关证据的质量和不确定性;6)干预的实施与复杂性/可行性;7)公平与伦理;8)总体背景。

结论

我们的综述对相关问题进行了全面分析,并就制定国家优先排序框架的考虑因素提出了关键建议。研究结果预计将对旨在确定医疗保健优先事项的不同公共组织有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6702737/dfef78d36ad0/40545_2019_181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6702737/dfef78d36ad0/40545_2019_181_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6702737/dfef78d36ad0/40545_2019_181_Fig1_HTML.jpg

相似文献

1
Systematic review for the development of a pharmaceutical and medical products prioritization framework.用于制定药品和医疗产品优先排序框架的系统评价。
J Pharm Policy Pract. 2019 Aug 21;12:21. doi: 10.1186/s40545-019-0181-2. eCollection 2019.
2
[Priority setting of health interventions. Review of criteria, approaches and role of assessment agencies].[卫生干预措施的优先排序。评估机构的标准、方法及作用综述]
Gac Sanit. 2017 Jul-Aug;31(4):349-357. doi: 10.1016/j.gaceta.2016.09.015. Epub 2017 Jan 3.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
6
Criteria Used for Priority-Setting for Public Health Resource Allocation in Low- and Middle-Income Countries: A Systematic Review.中低收入国家公共卫生资源分配的优先排序标准:系统评价。
Int J Technol Assess Health Care. 2019;35(6):474-483. doi: 10.1017/S0266462319000473. Epub 2019 Jul 16.
7
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).患者报告结局(PRO)在卫生技术评估(HTA)中的信息价值。
GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.
8
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians.旨在改善卫生系统管理人员、政策制定者和临床医生在决策过程中对系统评价的使用情况的干预措施。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009401. doi: 10.1002/14651858.CD009401.pub2.
9
Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.安抚奶嘴使用与母乳喂养、婴儿猝死综合征、感染及牙列不齐之间的关联。
JBI Libr Syst Rev. 2005;3(6):1-33. doi: 10.11124/01938924-200503060-00001.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project.一种用于确定新型冠状病毒肺炎(COVID-19)研究性治疗评估优先级的创新工具:一个试点项目。
Can Commun Dis Rep. 2024 Oct 3;50(10):357-364. doi: 10.14745/ccdr.v50i10a04. eCollection 2024 Oct.

本文引用的文献

1
Implementation Science to Advance Care Delivery: A Primer for Pharmacists and Other Health Professionals.实施科学以推进医疗服务提供:药剂师和其他卫生专业人员指南。
Pharmacotherapy. 2018 May;38(5):490-502. doi: 10.1002/phar.2114.
2
Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers.医疗保健决策中会考虑哪些标准?来自对政策和临床决策者的国际调查的见解。
Int J Technol Assess Health Care. 2013 Oct;29(4):456-65. doi: 10.1017/S0266462313000573.
3
A model for HTA priority setting: experience in Lithuania.
卫生技术评估优先事项设定模型:立陶宛的经验
Int J Technol Assess Health Care. 2013 Oct;29(4):450-5. doi: 10.1017/S0266462313000470.
4
Prioritizing investments in public health: a multi-criteria decision analysis.优先考虑对公共卫生的投资:多标准决策分析
J Public Health (Oxf). 2013 Sep;35(3):460-6. doi: 10.1093/pubmed/fds099. Epub 2012 Dec 14.
5
Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers.多标准健康干预措施优先级设定图:决策者的辅助工具。
BMC Health Serv Res. 2012 Dec 13;12:454. doi: 10.1186/1472-6963-12-454.
6
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking.从疗效到公平:资源配置和医疗保健决策的决策标准文献综述。
Cost Eff Resour Alloc. 2012 Jul 18;10(1):9. doi: 10.1186/1478-7547-10-9.
7
The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.EVIDEM框架及其在广泛的健康干预措施中确定优先事项方面的实用性。
Cost Eff Resour Alloc. 2011 Oct 26;9:16. doi: 10.1186/1478-7547-9-16.
8
Choosing health technology assessment and systematic review topics: the development of priority-setting criteria for patients' and consumers' interests.选择健康技术评估和系统综述课题:为患者和消费者利益设定优先顺序标准的制定。
Int J Technol Assess Health Care. 2011 Oct;27(4):348-56. doi: 10.1017/S0266462311000547.
9
Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.将健康技术评估(HTA)与多准则决策分析(MCDA)相结合,以实现高效的医疗保健决策:将 EVIDEM 框架应用于药品评估。
Med Decis Making. 2012 Mar-Apr;32(2):376-88. doi: 10.1177/0272989X11416870. Epub 2011 Oct 10.
10
Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights?卫生技术优先排序:优先考虑新技术的标准有哪些,以及它们的相对权重是什么?
Health Policy. 2011 Oct;102(2-3):126-35. doi: 10.1016/j.healthpol.2010.10.012. Epub 2010 Nov 11.